encoding CTX-M enzymes have spread rapidly in the past few decades in many parts of the world and are now the predominant type of ESBLs in E. coli [2, 3] . CTX-M enzymes, which now exceed 70 different types, can be divided into six clusters based on amino acid sequence similarities, namely, CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9, CTX-M- 25 , and CTX-M-45 [2] . The CTX-M-1 and CTX-M-9 clusters are distributed throughout many parts of the world, while CTX-M-2 and CTX-M-8 clusters are focally distributed in Europe [4] . In Korea, CTX-M-15 and CTX-M-3 were the most prevalent ESBLs according to a 2003 study of clinical E. coli isolates [5] .
Plasmid-mediated AmpC β -lactamases can also hydrolyze expanded-spectrum cephalosporins, but unlike ESBLs, they are not inactivated by clavulanic acid and are active against cephamycins. Since the initial finding of CMY-1 in Korea, various types of AmpC β -lactamases, including MIR, MOX, FOX, LAT, BIL, and DHA, have been reported [6] . In Korea, cefoxitin-resistant E. coli has become increasingly common, and a study performed in 2003 showed that a high portion (46.6%, 62/116) of cefoxitin resistance in E. coli were due to the production of plasmid-mediated AmpC β -lactamase [7] .
Acquisition of fluoroquinolone (FQ) resistance in Enterobacteriaceae is usually due to accumulation of mutations in chromosome-mediated target enzymes (DNA gyrase and topoisomerase IV) and/or to decreasing intracellular drug accumulation by upregulation of native efflux pumps either alone or in combination with decreased expression of outer membrane porins [8] . Thus, it was widely believed that FQ resistance was transferred only vertically. However, the recent discovery of plasmid-mediated FQ resistance determinants, specifically the Qnr protein and AAC(6' )-Ib-cr, has made it clear that FQ resistance can be transferred horizontally as well [9, 10] . Indeed, a study reported the detection of qnr genes in 2 of 260 clinical E. coli isolates obtained in Korea between 2001-2003 [11] .
Aminoglycosides are widely used to treat severe infections involving gram-negative bacteria, often in combination with broad-spectrum β -lactam antibiotics [12] . Aminoglycosides bind to the aminoacyl site of 16S ribosomal RNA (rRNA) within 30S ribosomal subunits and interfere with protein synthesis [13] ; however, a high level resistance to aminoglycosides mediated by methylation of 16S rRNA has recently emerged among gram-negative bacilli [14] .
The spread of plasmids containing multidrug-resistance determinants, including ESBL genes, is an emerging threat [10, 15] . Furthermore, ESBL-producing isolates usually show resistance to other antibiotics, including aminoglycosides and quinolones. The aims of the present study were to describe the characteristics of ESBL-producing urinary E. coli isolates from a Korean hospital, and to determine the prevalence of genes encoding AmpC β -lactamases, Qnr, AAC(6' )-Ib-cr, and 16S rRNA methylases in ESBL-producing isolates. 
MATERIALS AND METHODS

Bacterial strains
Antimicrobial susceptibility testing
Antibiotic-containing disks (BBL, Cockeysville, MD, USA)
were used for routine antibiograms by the CLSI disk diffusion assay [16] . The double-disk synergy (DDS) test was 
Mating-out assay
Conjugation experiments were carried out using the azideresistant recipient strain E. coli J53 by the broth mating method [17] . Transconjugants were selected on MacConkey agar containing azide (100 μ g/mL) and cefotaxime (2 μ g/mL).
PCR and sequencing experiments
Detection of genes coding ESBLs, AmpC β -lactamases, 
PCR target Primer name Primer sequence Reference
blaCTX-M (CTX-M-1 cluster) CTX-M-1F 5′ -GGACGTACAGCAAAAACTTGC-3′ CTX-M-1R 5′ -CGGTTCGCTTTCACTTTTCTT-3′ blaCTX-M (CTX-M-2 cluster) CTX-M-2F 5′ -CGGTGCTTAAACAGAGCGAG-3′ CTX-M-2R 5′ -CCATGAATAAGCAGCTGATTGCCC-3′ blaCTX-M (CTX-M-8 cluster) CTX-M-8F 5′ -ACGCTCAACACCGCGATC-3′ CTX-M-8R 5′ -CGTGGGTTCTCGGGGATAA-3′ blaCTX-M (CTX-M-9 cluster) CTX-M-9F 5′ -GATTGACCGTATTGGGAGTTT-3′ CTX-M-9R 5′ -CGGCTGGGTAAAATAGGTCA-3′ blaTEM TEM-F 5′ -ATGAGTATTCAACATTTCCGT-3′ [18] TEM-R 5′ -TTACCAATGCTTAATCAGTGA-3′ blaSHV SHV-F 5′ -CCGGGTTATTCTTATTTGTCGCT-3′ SHV-R 5′ -TAGCGTTGCCAGTGCTCG-3′ blaVEB VEB-F 5′ -ACCAGATAGGAGTACAGACATATGA-3′ VEB-R 5′ -TTCATCACCGCGATAAAGCAC-3′ blaGES/IBC GES/IBC-F 5′ -GTTAGACGGGCGTACAAAGATAAT-3′ GES/IBC-R 5′ -TGTCCGTGCTCAGGATGAGT-3′ blaTLA TLA-F 5′ -CGCGAAAATTCTGAAATGAC-3′ TLA-R 5′ -AGGAAATTGTACCGAGACCCT-3′ blaDHA-1-like DHA-F 5′ -GGGGAGATAACGTCTGACCA-3′ DHA-R 5′ -TAGCCAGATCCAGCAATGTG-3′ blaCMY-1-like CMY-1F 5′ -TCACATCGGCTTCACAGAGC-3′ CMY-1R 5′ -CCATGGTGATGCTGTCAAAGA-3′ blaCMY-2-like CMY-2F 5′ -CAACACGGTGCAAATCAAAC-3′ [19] CMY-2R 5′ -CATGGGATTTTCCTTGCTGT-3′ blaACT-1-like ACT-1F 5′ -CGTCATGGTCTCGTCCGTTAG-3′ ACT-1R 5′ -CCTTGACCTCATCCGGTACCT-3′ qnrA1 to qnrA6 QnrAm-F 5′ -AGAGGATTTCTCACGCCAGG-3′ QnrAm-R 5′ -TGCCAGGCACAGATCTTGAC-3′ qnrB1 to qnrB6 QnrBm-F 5′ -GGMATHGAAATTCGCCACTG-3′ QnrBm-R 5′ -TTTGCYGYYCGCCAGTCGAA-3′ [20] qnrS1 to qnrS2 QnrSm-F 5′ -GCAAGTTCATTGAACAGGGT-3′ QnrSm-R 5′ -TCTAAACCGTCGAGTTCGGCG-3′ aac(6′ )-Ib AAC(6′ )-IbF 5′ -TGACCAACAGCAACGATTCC-3′ [21] AAC(6′ )-IbR 5′ -TTAGGCATCACTGCGTGTTC-3′ armA armA-F 5′ -TATGGGGGTCTTACTATTCTGCCTAT-3′ armA-R 5′ -TCTTCCATTCCCTTCTCCTTT-3′ rmtA rmtA-F 5′ -CTAGCGTCCATCCTTTCCTC-3′ rmtA-R 5′ -TTTGCTTCCATGCCCTTGCC-3′ rmtB rmtB-F 5′ -TCAACGATGCCCTCACCTC-3′ rmtB-R 5′ -GCAGGGCAAAGGTAAAATCC-3′ [22] rmtC rmtC-F 5′ -GCCAAAGTACTCACAAGTGG-3′ rmtC-R 5′ -CTCAGATCTGACCCAACAAG-3′ rmtD rmtD-F 5′ -CTGTTTGAAGCCAGCGGAACGC-3′ rmtD-R 5′ -GCGCCTCCATCCATTCGGAATAG-3′ npmA npmA-F 5′ -CTCAAAGGAACAAAGACGG-3′ npmA-R 5′ -GAAACATGGCCAGAAACTC-3′
Other antimicrobial resistance genes in ESBLproducing isolates
Genes encoding DHA-1 and CMY-10 AmpC β -lactamases were detected in one and two CTX-M-3-harboring isolates, respectively. The qnrB4 and qnrS1 genes were detected each in one isolate harboring CTX-M-3 and CTX-M-15, respectively. Genes encoding AAC(6' )-Ib-cr were detected in 19 (70.4%) isolates, irrespective of the ESBL genotype. Lastly, the rmtB and armA genes, both of which encode a 16S rRNA methylase, were detected in one and four isolates, respectively.
Phenotypic characteristics of ESBL-producing isolates
The cefotaxime MICs for three isolates harboring CTX-M-14 were ≥256 μ g/mL, which was more than 16 times higher than ceftazidime MIC (4-16 μ g/mL) ( Table 2 
Phylogenetic groups
Most of the ESBL-producing isolates were within phylogenetic groups B2 (N=14, 51.9%) and D (N=7, 25.9%) ( Table   3 ). Five (83.3%) of the six isolates producing CTX-M-14 were within group D, while nine (64.3%) of the fourteen isolates producing CTX-M-15 were within group B2.
DISCUSSION
UTI is a common cause of morbidity in either healthy persons or in patients with various underlying diseases. The E. coli associated UTIs can progress to bacteremia, which are often treated with different broad-spectrum antibiotics because of concerns about infections with various resistant mechanisms [24] . Many antibiotics used in UTIs are usually capable of reaching and maintaining high urinary concentrations that are much greater than the MIC of the causative E. coli [25] . It might be argued that MIC and other pharmacokinetic parameters are less useful for the treatment of UTIs [25] .
In 2003, we showed that only 3.3% (8/246) of clinical E.
coli isolates produced CTX-M ESBLs [18] ; however, in the present study, the prevalence of these enzymes had increased another recent study [26] . Virulent extra-intestinal strains belong mainly to group B2 and, to a lesser extent, group D, whereas most commensal strains belong to group A and B1 [29] . A past report
showed that most FQ-resistant E. coli isolates that cause UTIs are from non-B2 groups (notably, group A, D, and B1) [30] . However, more than half (14/27) of our FQ-resistant E. coli isolates harboring CTX-M enzymes were within group B2. E. coli isolates within group B2 harbor many virulent factors [1] . Furthermore, strains producing CTX-M enzymes are more likely to cause repeated UTIs than strains that do not produce these enzymes, because strains producing CTX-M enzymes commonly contain iha, which encodes an adhesin-siderophore receptor associated with an increased risk for recurrent UTIs [31] .
In conclusion, CTX-M enzymes are the dominant type of ESBL found in urinary E. coli isolates. All of the isolates harboring CTX-M enzymes were resistant to ciprofloxacin, and it was not uncommon for these strains to also contain other antimicrobial resistance genes encoding AmpC β -lactamases, Qnr, AAC(6' )-Ib-cr, and 16S rRNA methylases.
More than half of the urinary E. coli isolates harboring CTX-M enzymes were within the phylogenetic group B2, and might therefore cause problematic and recurrent UTIs. 
